Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders
Shimels Tessema, Fellow in Pediatrics Hematology and Oncology at Addis Ababa University, Member of LOC for SIOP Africa 2028, shared on LinkedIn:
“Today people living with bleeding disorders and care givers Celebrate a landmark achievement!
Just yesterday ,May 21, 2026, the 79th World Health Assembly (WHA) unanimously adopted a resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders.
This is a historic development for the community and will contribute to increasing the diagnosis and level of care for people with inherited bleeding disorders around the world.
By adopting the WHA resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders, the WHO and its Member States (national governments) are elevating bleeding disorders on the global health agenda and are recognizing the need for strengthened global coordination and sustained policy action to address the health inequities affecting our community.
The World Hemophilia Federation call upon the WHO and all Member States to support effective implementation of this resolution to translate this political commitment into real-world impact for all people living with bleeding disorders across the globe.”
Stay updated with Hemostasis Today.
-
Jul 5, 2026, 04:54Saneha Anjum Shaik: What Every Clinician Should Know Before Ordering Blood Tests
-
Jul 5, 2026, 04:37Mathis Richter: How The Bone Marrow Responds To Myocardial Infarction Predicts Clinical Outcome
-
Jul 5, 2026, 02:45Marie Luise Hütter-Krönke: Can a Short Course of BCMA-Targeted Therapy Induce Long-Term Remission in Refractory Autoimmune Disease?
-
Jul 5, 2026, 02:24Shreya Agarwa: Transforming Care For Adolescents With Heavy Menstrual Bleeding
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins